Literature DB >> 34983798

Discontinuing antidepressants: Pearls and pitfalls.

Samantha J Zwiebel1, Adele C Viguera2.   

Abstract

Stopping antidepressants can be challenging due to the high rate of discontinuation symptoms. Patients with antidepressant discontinuation syndrome (ADS) commonly experience insomnia, flu-like symptoms, mood disturbances, dizziness, and paresthesias, but a broad array of adverse effects is possible. Symptoms can last for days to months, and different symptoms have different durations. Patient education, identification of patients most at risk for developing symptoms, and a slow antidepressant taper or cross-taper are important steps in mitigating the risk of ADS and managing patient concerns about ADS. Tapers should be carried out over weeks to months. Discontinuation symptoms should be managed with restarting the prior dose of antidepressant and then tapering even more slowly, with additional symptomatic management as needed.
Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34983798     DOI: 10.3949/ccjm.89a.21020

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  1 in total

1.  Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.

Authors:  Yumi Aoki; Yoshikazu Takaesu; Hajime Baba; Jun-Ichi Iga; Hikaru Hori; Takeshi Inoue; Kazuo Mishima; Aran Tajika; Masaki Kato
Journal:  Neuropsychopharmacol Rep       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.